GROUP ONE TRADING, L.P. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$6,000
-66.7%
2,976
-62.7%
0.00%
Q4 2020$18,000
+20.0%
7,976
+65.3%
0.00%
Q2 2020$15,000
+66.7%
4,824
+1.4%
0.00%
Q1 2020$9,000
+200.0%
4,759
+499.4%
0.00%
Q3 2019$3,000
-95.4%
794
-94.9%
0.00%
-100.0%
Q2 2019$65,000
+282.4%
15,562
+213.4%
0.00%
Q4 2018$17,000
-94.0%
4,965
-89.4%
0.00%
-100.0%
Q3 2018$282,000
-59.1%
46,965
-56.7%
0.00%
-66.7%
Q2 2018$690,000
+2775.0%
108,491
+2005.8%
0.01%
Q1 2018$24,000
-51.0%
5,152
-77.7%
0.00%
Q3 2017$49,00023,0520.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders